Figure 3
Figure 3. Analysis of GATA2 mutants by transcription assays in HEK 293T cells. Bars indicate fold activation of the luciferase reporters in at least 3 independent experiments, each performed in triplicates. Errors bars represent standard error of the mean. P values are indicated for pairwise comparisons using Student t test. (A) A GATA2-responsive reporter (GATA-LUC) containing GATA-binding elements derived from the TCRδ enhancer was cotransfected with expression plasmids for either GATA2 wild-type or GATA2 mutants. A reduced activation was observed for mutants A318T and L321F compared with wild-type GATA2. In contrast, an increased activation was observed for the G320D mutant. The L359V mutant of GATA2, located in ZF2, which is found in ∼ 10% of patients at the progression of CML to AML,21 did not show a significant difference in transcriptional activation compared with wild-type GATA2. (B) A CEBPA-responsive reporter (4xCAAT-BS-TK-LUC) containing CEBPA-binding elements was cotransfected with expression plasmids for wild-type CEBPA or a p30 CEBPA truncation mutant in combination with either GATA2 wild type or GATA2 mutants. Enhancement of CEBPA-dependent transcriptional activation by wild-type GATA2 was significantly reduced for all the ZF1-mutants but not for L359V ZF2 mutant. Residual activation of the reporter by the p30 CEBPA truncation mutant was enhanced by coexpression of wild-type GATA2 (dashed line), but this enhancement was markedly reduced for all of the GATA2 mutants tested.

Analysis of GATA2 mutants by transcription assays in HEK 293T cells. Bars indicate fold activation of the luciferase reporters in at least 3 independent experiments, each performed in triplicates. Errors bars represent standard error of the mean. P values are indicated for pairwise comparisons using Student t test. (A) A GATA2-responsive reporter (GATA-LUC) containing GATA-binding elements derived from the TCRδ enhancer was cotransfected with expression plasmids for either GATA2 wild-type or GATA2 mutants. A reduced activation was observed for mutants A318T and L321F compared with wild-type GATA2. In contrast, an increased activation was observed for the G320D mutant. The L359V mutant of GATA2, located in ZF2, which is found in ∼ 10% of patients at the progression of CML to AML,21  did not show a significant difference in transcriptional activation compared with wild-type GATA2. (B) A CEBPA-responsive reporter (4xCAAT-BS-TK-LUC) containing CEBPA-binding elements was cotransfected with expression plasmids for wild-type CEBPA or a p30 CEBPA truncation mutant in combination with either GATA2 wild type or GATA2 mutants. Enhancement of CEBPA-dependent transcriptional activation by wild-type GATA2 was significantly reduced for all the ZF1-mutants but not for L359V ZF2 mutant. Residual activation of the reporter by the p30 CEBPA truncation mutant was enhanced by coexpression of wild-type GATA2 (dashed line), but this enhancement was markedly reduced for all of the GATA2 mutants tested.

Close Modal

or Create an Account

Close Modal
Close Modal